Privacy    
 
  Citi Research Disclosures


ABCDEFGHIJKLMNOPQRSTUVWXYZ#




Disclosures Home
Conflicts Management Policy
SEBI Investor Charter & Complaint Information
SEBI Prescribed Client Terms & Conditions
SEBI Compliance Audit Report
Staff Conflicts
Terms of Use

 
Valuation & Risks ( SRENH.S ) Disclosure / Price Chart(s) / Valuation & Risk
Fundamental Equity Research
We set a CHF 169.8 target price based on a sum-of-the-parts valuation. We apply a 12.3x multiple for P&C Re, 12.1x for L&H Re and 12.9x for CorSo. Based on 2025 normalised EPS our valuation equates to 12.3x EPS.

We see the following industry and company-specific risk factors to our target price. The company is exposed to natural catastrophe risks to a greater extent than peers, which may result in upside or downside risk if loss experience deviates significantly from expected levels. Covid-19 pandemic risks remain elevated, particularly around mortality losses, and actual experience may be better or worse than we currently assume.

 

 

citiPrivacy
www.citigroup.com Terms, conditions, caveats, and small print
Copyright © 2025 Citi